Addus HomeCare Corp(ADUS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 21.27 | EPS (ttm) | 5.7 | Insider Own | 2.89% | Shs Outstand | 18.7M | Perf Week | 2.72% |
| Market Cap | 2.26B | Forward P/E | 16.08 | EPS next Y | 7.01% | Insider Trans | -0.15% | Shs Float | 18.1M | Perf Month | 8.34% |
| Enterprise Value | 2.27B | PEG | 1.84 | EPS next Q | 1.79 | Inst Own | 104.73% | Short Float | 4.27% | Perf Quarter | 1.77% |
| Income | 0.11B | P/S | 1.53 | EPS this Y | 13.12% | Inst Trans | 1.49% | Short Ratio | 3.8 | Perf Half Y | 22.66% |
| Sales | 1.48B | P/B | 1.97 | EPS next 5Y | 8.72% | ROA | 7.35% | Short Interest | 0.77M | Perf YTD | 12.9% |
| Book/sh | 61.48 | P/C | 22.74 | EPS past 3/5Y | 22.39% 20.22% | ROE | 9.71% | 52W High | -2.57% ($124.43) | Perf Year | -0.18% |
| Cash/sh | 5.33 | P/FCF | 14.63 | Sales past 3/5Y | 14.36% 13.22% | ROIC | 8.47% | 52W Low | 37.85% ($87.95) | Perf 3Y | 47.98% |
| Dividend Est. | - | EV/EBITDA | 12.85 | EPS Y/Y TTM | 25.01% | Gross Margin | 31.23% | Volatility(W/M) | 2.36% 2.31% | Perf 5Y | 45.09% |
| Dividend TTM | - | EV/Sales | 1.54 | Sales Y/Y TTM | 15.88% | Oper. Margin | 10.85% | ATR (14) | 2.74 | Perf 10Y | 379.59% |
| Dividend Ex-Date | - | Quick Ratio | 1.69 | EPS Q/Q | 24.24% | Profit Margin | 7.13% | RSI (14) | 64.56 | Recom | 1.64 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.69 | Sales Q/Q | 8.01% | SMA20 | 4.58% ($115.93) | Beta | 0.77 | Target Price | $134.08 |
| Payout | - | Debt/Eq | 0.09 | Earnings | 2026/11/3 | SMA50 | 3.86% ($116.73) | Rel Volume | 1.07 | Prev Close | $121.17 |
| Employees | 50659 | LT Debt/Eq | 0.08 | EPS/Sales Surpr. | 1.88% 0.31% | SMA200 | 14.21% ($106.16) | Avg Volume(3M) | 0.20M | Price | $121.24 |
| IPO | 2009/10/28 | Option/Short | Yes/Yes | Trades | 4942 | Volume | 216,713 | Change | 0.06% |
🏡 This is a U.S. healthcare company that provides home care and in-home medical services. It offers home-based care and medical services, including personal care services for seniors and people with disabilities, home-visit medical care, and hospice, operating its business primarily through government programs and insurance. The company has established itself as a home care and medical services provider specializing in in-home care.
Over the past 1 year, on the higher side
3% below its 1-year high.
Traded about as much as usual. That is 107% of its average volume.
Next earnings report: November 3
6 days to go.
ADUS makes money exceptionally well
Of every $100 in sales, $10.85 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +13.1% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,285. Peers typically go for $1,288. Compared with its own 5-year average, it is 20% cheaper now.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +45.1%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 104.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #20 of 48 in the industry
Based on market cap of $2B.
FAQ
What kind of company is ADUS?
ADUS belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of ADUS?
The market cap of ADUS is approximately $2.3B, ranking 1,961 within its sector.
What is the P/E ratio of ADUS?
ADUS has a P/E ratio of approximately 21.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ADUS?
ADUS has recorded a 52-week high of $124.43 and a low of $87.95.
